High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA.-L. Taksin, Sylvie Castaigné, H. Farhat et al.|Leukemia|2006Cited by 295